contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dignitana-ab-dignicap-delta-study-underway-in-brindisi-italy

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Dignitana

Dignitana announces that Antonio Perrino Hospital in Brindisi, Italy has initiated a clinical study of the DigniCap Delta Scalp Cooling System which features advanced thermoelectric cooling....

<div class="abstract">Dignitana announces that Antonio Perrino Hospital in Brindisi, Italy has initiated a clinical study of the DigniCap Delta Scalp Cooling System which features advanced thermoelectric cooling. The FDA-cleared DigniCap Scalp Cooling System minimizes hair loss from chemotherapy for cancer patients&nbsp;with solid tumors such as breast, prostate, and gynecological cancers.</div>Led by Dr. Dario Loparco, Breast Unit psycho-oncologist and DigniCap protocol manager at the ASL Brindisi Breast Unit,&nbsp; the study is focused on breast cancer patients being treated with one of the most challenging chemotherapy regimens for hair retention -- epirubicin, cyclophosphamide and docetaxel (EC-T)."DigniCap is quickly becoming standard of care in Italy and we are proud to have offered this life-changing therapy since 2015. &nbsp;In a disease where so much is out of their control, cancer patients need to have the opportunity to preserve their hair during chemotherapy - and DigniCap gives them that choice," said Dr. Loparco.Dr. Loparco and the oncology team at Antonio Perrino Hospital have published three previous clinical studies using the legacy DigniCap C3 system. Those studies demonstrated DigniCap success rates of 71 percent&nbsp;(<a href="http://dx.doi.org/10.2217/fon-2019-0066">http://dx.doi.org/10.2217/fon-2019-0066</a>), 71.7 percent&nbsp;(<a href="http://dx.doi.org/10.1093/annonc/mdz240.026">http://dx.doi.org/10.1093/annonc/mdz240.026</a>), and 72.8 percent&nbsp;(<a href="http://dx.doi.org/10.1093/annonc/mdy300.109">http://dx.doi.org/10.1093/annonc/mdy300.109</a>) using a variety of chemotherapy regimens in breast cancer patients.Recognized internationally as a standard of care and quality of life advancement for cancer patients, scalp cooling is listed as a treatment recommendation in the clinical practice guidelines published by&nbsp;European Society for Medical Oncology&nbsp;(<a href="https://www.annalsofoncology.org/article/S0923-7534(20">https://www.annalsofoncology.org/article/S0923-7534(20</a>)43157-6/fulltext)&nbsp;(ESMO),&nbsp;National Comprehensive Cancer Network&nbsp;(<a href="https://nccn.org/">https://nccn.org/</a>)® (NCCN) and&nbsp;Cancer Australia&nbsp;(<a href="https://www.guidancebreastcancer.gov.au/sites/default/files/guidelines/GEBC_Recommendations%20and%20practice%20points_Pdf_Sept%202020.pdf">https://www.guidancebreastcancer.gov.au/sites/default/files/guidelines/GEBC_Recommendations%20and%20practice%20points_Pdf_Sept%202020.pdf</a>).